If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVela Technologies Share News (VELA)

Share Price Information for Vela Technologies (VELA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0115
Bid: 0.011
Ask: 0.012
Change: -0.001 (-8.00%)
Spread: 0.001 (9.091%)
Open: 0.0125
High: 0.0125
Low: 0.0115
Prev. Close: 0.0125
VELA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Inland Homes appoints administrators; EDX buys Hutano

Wed, 27th Sep 2023 19:43

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Vela Technologies PLC - Early stage-focused technology investor - Reports total assets of GBP5.9 million as of June 30, down 6.2% from GBP6.3 million at March 31. Cash balance at June 30 was GBP34,000, versus GBP721,000 at March 31, while Vela's fair value of investments was GBP5.8 million from GBP5.5 million. During the quarter, Vela entered into a put option for the potential sale of its economic interest in AZD1656 for a total consideration of GBP4.0 million. The option was granted by Conduit Pharmaceuticals Ltd and Murphy Canyon Acquisition Corp. Should the option be exercised by Vela, the consideration that would be payable to Vela would be satisfied through the issuance of new shares in the combined company. Executive Director James Normand says: "Market valuations of Vela's listed investee companies remain, like so many others in the small- and micro-cap sector, well below the valuations that one would expect to be applied in 'normal' stock market times. The directors of Vela believe, however, that a number of its investee companies have huge potential; and have therefore determined to hold the shares in those companies until the market cycle results in valuations that are more appropriate to their respective trading and prospects. The board is particularly pleased that the risk taken nearly three years ago in investing in the development of the AZD1656 drug is at the point where a suitable reward can be reaped."

----------

UniVision Engineering Ltd - Hong Kong-based company that supplies, designs, installs and maintains closed-circuit television and surveillance systems, and also sells security-related products - Says that it needs more time to complete its audit and will have to delay the announcement of its results for the year ended March 31 and the publication of its Annual Report and Accounts for the same period. Adds that it needs more time to assess the up-to-date position regarding previously announced legal disputes, including the winding-up petitions brought against the company announced on July 28, August 29 and September 14. These petitions are being opposed by the company and it remains in negotiations with all parties. The first of these petitions was due to be heard in the High Court in Hong Kong on Wednesday, but was adjourned until October 11. The firm's shares will be suspended from October 2.

----------

British Smaller Cos VCT PLC - Leeds, England-based venture capital trust - Further to the launch of new shares offers on September 20, announces with British Smaller Companies VCT2 PLC that the application forms are now available and are being processed. The new share offers in the 2023/24 tax year are seeking to raise, in aggregate, up to GBP65 million, with an over-allotment facility of up to a further GBP25 million, in aggregate, by way of prospectus offers of new ordinary shares for subscription. The deadline for the receipt of applications and cleared funds is March 28, 2024, or earlier if the offers become fully subscribed.

----------

Inland Homes PLC - Southern England-focused brownfield developer, housebuilder and partnership housing company - Resolves to proceed with the process of appointing David Hudson and Phil Armstrong of FRP Advisory Trading Ltd as administrators of the company. Adds that some of its subsidiaries which have granted floating charges have also filed notices of intention to appoint administrators. Says this follows a review by FRP Advisory, which has provided "sufficient indication" that further work is still required before the preparation of financial statements could be completed and then audited. Inland says the extent of further work and cost required to complete the preparation of the financial statements and the audit for financial 2022 cannot be certain at this stage, and the timeframe within which this might be feasible is not known. Accordingly, Inland anticipates that admission of its shares to AIM will be cancelled on October 4.

----------

Guanajuato Silver Co Ltd - Mexico-focused precious metals explorer and producer - Says measured and indicated resources at San Ignacio more than doubled, totalling 790,000 tonnes. Chair James Anderson says: "The significant increase in the San Ignacio mineral resource across all categories can be attributed to the exceptional work on the part of our Mexican exploration teams; their efforts over the past year have expanded our understanding of the mineralized systems in place at San Ignacio while returning consistently high-grade results, some of which are highlighted below, that have led to an increase of 130% in the measured & indicated category and 283% in the inferred category."

----------

EDX Medical Group PLC - London-based developer of diagnostics products to help predict disease risk - Buys Hutano Diagnostics Ltd , to be met by the issue of 9.1 million new shares at 11 pence each. Up to 1.8 million additional consideration shares will be issued to the vendors on the achievement of certain commercial milestones. Says the acquisition will enable EDX Medical Group to accelerate and expand its point-of-care testing capabilities with a range of innovative tests capable of accurately measuring a combination of multiple disease markers on a single device within minutes. The new, miniaturised tests are expected to enable the identification of up to 10 disease markers simultaneously.

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
31 Dec 2021 09:09

IN BRIEF: Vela Technologies upbeat on future despite widening loss

IN BRIEF: Vela Technologies upbeat on future despite widening loss

Read more
30 Dec 2021 13:59

IN BRIEF: Vela Technologies proposes 50-into-1 share consolidation

IN BRIEF: Vela Technologies proposes 50-into-1 share consolidation

Read more
14 Dec 2021 21:51

IN BRIEF: Positive results for Covid-19 treatment boosts Vela

IN BRIEF: Positive results for Covid-19 treatment boosts Vela

Read more
14 Dec 2021 10:47

AIM WINNERS & LOSERS: Bad Black Friday for Joules; Cohort's Chess pain

AIM WINNERS & LOSERS: Bad Black Friday for Joules; Cohort's Chess pain

Read more
1 Dec 2021 16:38

IN BRIEF: Shares in e-learning firm Skillcast rise 14% on AIM debut

IN BRIEF: Shares in e-learning firm Skillcast rise 14% on AIM debut

Read more
1 Dec 2021 11:02

AIM WINNERS & LOSERS: Vela Tech rises as Skillcast AIM debut goes well

AIM WINNERS & LOSERS: Vela Tech rises as Skillcast AIM debut goes well

Read more
17 Nov 2021 20:31

Vela and Primorus Investments note Boanerges takeover of WeShop

Vela and Primorus Investments note Boanerges takeover of WeShop

Read more
30 Sep 2021 11:21

TRADING UPDATES: Avation wings clipped by virus; Zaim swings to profit

TRADING UPDATES: Avation wings clipped by virus; Zaim swings to profit

Read more
17 Sep 2021 14:53

TRADING UPDATES: Oilex plans Cambay wells; eEnergy buys UtilityTeam

TRADING UPDATES: Oilex plans Cambay wells; eEnergy buys UtilityTeam

Read more
9 Sep 2021 12:05

IN BRIEF: Vela Technologies Covid-19/diabetes drug trials successful

IN BRIEF: Vela Technologies Covid-19/diabetes drug trials successful

Read more
6 Sep 2021 15:52

Vela confirms slight delay to Arcadia clinical trial report

(Sharecast News) - Vela Technologies announced a delay to the results of the clinical trial of 'SGS002' on Monday, to 10 September.

Read more
1 Sep 2021 14:07

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

Read more
5 Aug 2021 11:35

Cornerstone FS awarded e-money institution status by UK regulator

Cornerstone FS awarded e-money institution status by UK regulator

Read more
23 Jul 2021 21:13

IN BRIEF: Vela Technologies in advanced stages of appointing director

IN BRIEF: Vela Technologies in advanced stages of appointing director

Read more
23 Jul 2021 13:03

Vela Technologies in 'advanced states' of new director appointment

(Sharecast News) - Vela Technologies updated the market on its intention to add another director to the board on Friday, saying it was in the "advanced stages" of appointing an executive director.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.